Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease.
about
Arginine deprivation and immune suppression in a mouse model of Alzheimer's diseaseDopamine receptor activation increases HIV entry into primary human macrophagesInteraction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolateDeterminants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domainsSyndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.Immune function of microglia.Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in bloodHIV-1 target cells in the CNS.Human retinal microglia express candidate receptors for HIV-1 infection.CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis.Microglia in the developing brain: a potential target with lifetime effects.The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitorsMicroglia: gatekeepers of central nervous system immunology.Isolation of primary microglia from the human post-mortem brain: effects of ante- and post-mortem variables.Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants.Central nervous system myeloid cells as drug targets: current status and translational challenges.Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhMacrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.Differential expression of CD45 on canine microglial cells.Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry.Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE.Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex.Phenotyping primary human microglia: tight regulation of LPS responsiveness.Characterizing primary human microglia: A comparative study with myeloid subsets and culture models.An optimized protocol for the acute isolation of human microglia from autopsy brain samples.Microglia in the cerebral wall of the human telencephalon at second trimester.In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques.
P2860
Q28391826-2D2365BF-E5FE-4FF0-8FE6-D61B84D031E1Q28543414-6773A5CC-3714-4BFC-856F-8450EA74888CQ33788874-EBA3FEA9-D568-4D52-A7ED-7E8CF15C850BQ33796067-8168AFCA-700F-412C-BAD0-0BC8457D60A6Q33845503-0AA16C5D-8D80-45A8-9BBF-A20CBA967E92Q33851094-05CF2DA4-7925-4323-A0FB-B0A95A5328EFQ34094707-27C9683D-82CF-4BD4-84EC-94C259A37A23Q34605219-3E06FB80-3103-4C1E-AD20-E57D3D281ADDQ35088079-3EE4D2AE-6002-46C3-BF8D-5E479FD1AC41Q35196509-67631368-1A92-4E6F-BFAE-81CBBA23A313Q35593291-3D4BF568-A3F7-4FAB-BAB0-5EA20FC222A3Q35648977-7A4AC80D-1B10-40EC-B8F9-F6B6E43A915FQ35823222-368EB3DA-6F14-4A31-8FF4-EF8824D33427Q36957295-A7EAD22E-4B7D-4F5E-BB3F-3525D74E3C53Q37333298-A5A150B0-20FA-4126-B589-BD97FCB0D206Q37651013-3F64BFDF-425F-4B5A-80FA-F5022DC16F5EQ37765920-9736C7E9-91BA-471C-A8C5-B53AF70F6F41Q38658658-A70D3C61-A866-49DA-B5A2-5952718E9E05Q39351562-3EDCC5A9-C1C5-44D9-BFFD-238FA8E50D4BQ39521282-354A8504-D87B-4F20-A662-CF0EC0EDF07FQ40190703-AEA6A130-2F6F-4584-9D96-E8E1C3AFC988Q43069789-9FCEB77D-FBA6-4FFD-9AF9-460C5E5E6945Q47845788-137BC163-5140-44E2-872C-AD8CE7D3D33CQ48176951-80F27626-50B0-482C-8718-47E268FC9198Q48458622-7D0BD77F-F324-4636-9F42-FDF52F380EF1Q48612381-5744E238-F6DD-4AEA-812E-EF6437E3131EQ48849720-D5818DBA-DAF0-411A-A2C3-6E3B6B7F79C1Q52086723-E0784B32-5676-499F-8141-40912FBC3ABEQ52623429-8AAD4956-875A-41D3-A366-7A7E79AFD16B
P2860
Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Direct ex vivo flow cytometric ...... th other neurological disease.
@en
Direct ex vivo flow cytometric ...... th other neurological disease.
@nl
type
label
Direct ex vivo flow cytometric ...... th other neurological disease.
@en
Direct ex vivo flow cytometric ...... th other neurological disease.
@nl
prefLabel
Direct ex vivo flow cytometric ...... th other neurological disease.
@en
Direct ex vivo flow cytometric ...... th other neurological disease.
@nl
P2093
P921
P1433
P1476
Direct ex vivo flow cytometric ...... th other neurological disease.
@en
P2093
P304
P356
10.1097/00002030-199714000-00006
P407
P577
1997-11-01T00:00:00Z